-- Sanofi-Aventis Will Return Influenza Vaccine Commercial Rights to Crucell
-- David Whitehouse
-- 2010-07-08T05:52:53Z
-- http://www.bloomberg.com/news/2010-07-08/sanofi-aventis-will-return-influenza-vaccine-commercial-rights-to-crucell.html

          
          
             Sanofi Aventis SA will return
commercial rights to the FluCell influenza vaccine to Crucell
NV, the Dutch company said in a statement on Hugin.  
 Crucell will waive its existing right to exit an agreement
with Sanofiâ€™s Shantha Biotechnics to develop paediatric
medecines, the statement said.  
          
          


  


        